Therapeutic Strategies During Cenobamate Treatment Initiation
This MEDtalk highlights Dr. Elinor Ben-Menachem’s expertise in epilepsy research, focusing on the newly approved anti-seizure medication cenobamate. With its dual mechanism of action, cenobamate shows potential as a highly effective treatment for focal-onset seizures, offering new hope for patients when carefully managed with existing therapies.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in